Matsuhiko Oka

Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study

Ryo Okubo, Minori Koga, Noriko Katsumata et al. · Journal of Affective Disorders · 2018 · 138 citations

Psychiatry, Psychotic Disorder, Proof-of-concept Study +8

<p>Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)</p>

Naoki Hashimoto, Atsuhito Toyomaki, Matsuhiko Oka et al. · Neuropsychiatric Disease and Treatment · 2019 · 14 citations · Full text

Changes in subunit composition of NMDA receptors in animal models of schizophrenia by repeated administration of methamphetamine

Matsuhiko Oka, Koki Ito, Minori Koga et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2020 · 14 citations · Full text

Subunit Composition, Neuropsychology, Psychoactive Drug +14

The mediator effect of personality traits on the relationship between childhood abuse and depressive symptoms in schizophrenia

Ryo Okubo, Takeshi Inoue, Naoki Hashimoto et al. · Psychiatry Research · 2017 · 12 citations

Mediator Effect, Psychopathology, Psychiatry +11

Plasma fatty acid-binding protein 7 concentration correlates with depression/anxiety, cognition, and positive symptom in patients with schizophrenia

Minori Koga, Shin Nakagawa, Asumi Sato et al. · Journal of Psychiatric Research · 2021 · 12 citations · Full text

Psychopathology, Psychiatry, Psychotic Disorder +12